160 related articles for article (PubMed ID: 6396766)
81. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base.
Jones SE; Moon TE; Bonadonna G; Valagussa P; Rivkin S; Buzdar A; Montague E; Powles T
Am J Clin Oncol; 1987 Oct; 10(5):387-95. PubMed ID: 3310603
[TBL] [Abstract][Full Text] [Related]
82. [Adjuvant therapy of breast cancer. 1: Cytostatic therapy].
Possinger K; Sauer HJ; Wilmanns W
Fortschr Med; 1986 Aug; 104(29):552-5. PubMed ID: 3758881
[No Abstract] [Full Text] [Related]
83. Adjuvant chemotherapy in breast cancer: back to the future.
Colleoni M; Goldhirsch A
Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
[No Abstract] [Full Text] [Related]
84. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
Mikhak B; Zahurak M; Abeloff MD; Fetting JH; Davidson NE; Donehower RC; Waterfield W; Kennedy MJ
Cancer; 1999 Feb; 85(4):899-904. PubMed ID: 10091768
[TBL] [Abstract][Full Text] [Related]
85. Chemotherapy induces regression of brain metastases in breast carcinoma.
Rosner D; Nemoto T; Lane WW
Cancer; 1986 Aug; 58(4):832-9. PubMed ID: 3755076
[TBL] [Abstract][Full Text] [Related]
86. Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.
Wolmark N; Fisher B
World J Surg; 1985 Oct; 9(5):699-706. PubMed ID: 2856855
[No Abstract] [Full Text] [Related]
87. Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
Ragaz J; Spinelli JJ
Int J Cancer; 2000 Aug; 87(3):423-6. PubMed ID: 10897049
[No Abstract] [Full Text] [Related]
88. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
Walther PJ
Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
[No Abstract] [Full Text] [Related]
89. The response to further chemotherapy in patients with carcinoma of the breast who progressed while receiving adjuvant therapy.
Morris DM; Elias EG; Didolkar MS; Brown SD
J Surg Oncol; 1985 Jul; 29(3):154-7. PubMed ID: 3001423
[TBL] [Abstract][Full Text] [Related]
90. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
Fisher B; Brown AM; Dimitrov NV; Poisson R; Redmond C; Margolese RG; Bowman D; Wolmark N; Wickerham DL; Kardinal CG
J Clin Oncol; 1990 Sep; 8(9):1483-96. PubMed ID: 2202791
[TBL] [Abstract][Full Text] [Related]
91. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
[TBL] [Abstract][Full Text] [Related]
92. Neoadjuvant treatment in young women with breast cancer.
Barnadas A
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():35-8. PubMed ID: 20711668
[No Abstract] [Full Text] [Related]
93. CAF in metastatic breast cancer: standard therapy or another effective regimen?
Hayes DF; Henderson IC
J Clin Oncol; 1987 Oct; 5(10):1497-9. PubMed ID: 3309195
[No Abstract] [Full Text] [Related]
94. Management of inflammatory carcinoma of the breast. A combined modality approach.
Fastenberg NA; Martin RG; Buzdar AU; Hortobagyi GN; Montague ED; Blumenschein GR; Jessup JM
Am J Clin Oncol; 1985 Apr; 8(2):134-41. PubMed ID: 3841746
[TBL] [Abstract][Full Text] [Related]
95. Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.
Hryniuk WM; Levine MN; Levin L
NCI Monogr; 1986; (1):87-94. PubMed ID: 3534595
[TBL] [Abstract][Full Text] [Related]
96. The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.
Sorace RA; Bagley CS; Lichter AS; Danforth DN; Wesley MW; Young RC; Lippman ME
World J Surg; 1985 Oct; 9(5):775-85. PubMed ID: 2998103
[No Abstract] [Full Text] [Related]
97. Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Lichtman SM; Budman D; Bosworth H; Allen S; Schulman P; Weiselberg L; Weiss R; Lehrman D; Vinciguerra V
Am J Clin Oncol; 1991 Aug; 14(4):317-21. PubMed ID: 1907428
[TBL] [Abstract][Full Text] [Related]
98. New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
Bonadonna G; Bignami P; Buzzoni R; Moliterni A; Valagussa P; Veronesi U
Recent Results Cancer Res; 1984; 91():210-3. PubMed ID: 6374799
[No Abstract] [Full Text] [Related]
99. Adjuvant use of cytotoxic chemotherapy to destroy micrometastasis in breast cancer after local control therapy--current status.
Carter SK
Clin Exp Metastasis; 1983; 1(1):1-15. PubMed ID: 6399695
[No Abstract] [Full Text] [Related]
100. Treatment of advanced breast cancer with chemotherapy.
Ward JH; Eyre HJ
Semin Surg Oncol; 1988; 4(4):256-60. PubMed ID: 3073490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
